The fast pace of innovation in IT offers compelling investment opportunities

Truffle Capital is a pioneer investor in the exciting field of Energy

Biotechnology has radically transformed medicine over the past 25 years


  • “ An industrial partner, demanding and understanding at the same time, who knows that value creation is a long term process. ”Wittycell et PlasmaPrime
    Miguel Sieler, Chairman

Truffle Capital is an independent European venture capital firm

Truffle Capital is an independent venture capital firm investing in Europe. Established in 2001 and with over €520 million under management and advisory as of the 30th of September 2012, Truffle Capital is an important and independent European private equity firm, specialized in investments in spin-offs from companies active in the Energy, Information Technology and Life Sciences sectors. The firm is led by a team of four General Partners with decades of successful investment and entrepreneurial experience in both Europe and in the USA.

Backed by an investment team of international experts and an experienced support team, a total of 15 professionals, Truffle Capital aims to achieve superior financial returns by leveraging its industry knowledge, extensive network, and operational experience to identify business opportunities that match latent market needs.


05-2013

TRUFFLE INSIDERS – APRIL 2013


+ read more
04-2013

PROSEP

ProSep awarded $2 million contract for produced water treatment solution

+ read more
04-2013

SYMETIS

Symetis’ Accurate TA confirms superior results

Pdf


+ read more
04-2013

THERADIAG

Theradiag granted 1.2 million euros by Oseo as part of the collaborative project CaReNa

Pdf


+ read more